Organization & Developments: Alcyone Therapeutics

Parents

*Alcyone Therapeutics is a clinical-stage biotechnology company committed to transforming pediatric care through a diversified portfolio of precision CNS therapeutics and dosing platforms. :*The Company is advancing a therapeutic pipeline in collaboration with Nationwide Children’s Hospital (AWRI) focused on severe pediatric neurological diseases. :*Alcyone’s lead programs include miRNA sponge for X chromosome reactivation to treat X-linked genetic disorders, including Rett syndrome and a clinical-stage gene therapy for CLN3 Batten disease and a follow-on pipeline that includes EPH-101, targeting Ephrin pathway to address neurodegeneration. Alcyone’s proprietary FalconTM precision intra-cerebrospinal fluid (CSF) drug transport modeling and delivery platform technology incorporates deep knowledge of CSF dynamics, artificial intelligence, computational modeling, and bioengineering.:* This comprehensive approach allows for the optimization of central nervous system (CNS) dosing and delivery to better target the